NCT02257307

Brief Summary

Evaluating retinopathy of prematurity (eROP) ancillary study Implementation Project is a multi-center observational study will focus on feasibility, and relative cost-effectiveness of an retinopathy of prematurity (ROP) telemedicine evaluation system to detect eyes of at-risk babies and provide timely feedback to the examining ophthalmologist at the Clinical Center.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
244

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2014

Geographic Reach
1 country

5 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 2, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 6, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 16, 2016

Completed
Last Updated

April 13, 2017

Status Verified

April 1, 2017

Enrollment Period

9 months

First QC Date

October 2, 2014

Last Update Submit

April 11, 2017

Conditions

Keywords

ROPretinopathyReferral warranted retinopathy

Outcome Measures

Primary Outcomes (1)

  • Determine whether imaging evaluation can be achieved for each baby within 24 hours following uploading of images in order to provide timely feedback to the examining ophthalmologist.

    Interval from uploading the images to the secure server to the time a grading report is submitted to the Clinical Center

    6 months

Interventions

De-identified digital images of both eyes, obtained by a non-physician Certified ROP Imager (CRI) using the RetCam Shuttle, will be uploaded to the secure server for remote evaluation by a Trained Reader. The results of the Reader's evaluation will be reported to the Clinical Center.

Eligibility Criteria

Age32 Weeks - 40 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Premature babies (N=500) with birth weights of \<1251g who meet current ROP screening guidelines in 5 NICUs in US.

You may qualify if:

  • Babies with birth weights of \<1251g
  • Babies having clinical examinations to screen for ROP

You may not qualify if:

  • Referral from an outside hospital for treatment of serious ROP that is performed before imaging can be obtained.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Johns Hopkins University

Baltimore, Maryland, 21205, United States

Location

University of Oklahoma

Oklahoma City, Oklahoma, 73104, United States

Location

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

Location

Vanderbilt University

Nashville, Tennessee, 37232, United States

Location

University of Utah

Salt Lake City, Utah, 84132, United States

Location

MeSH Terms

Conditions

Retinopathy of PrematurityRetinal Diseases

Condition Hierarchy (Ancestors)

Eye DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Graham E Quinn, MD, MSCE

    Children's Hospital of Philadelphia

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2014

First Posted

October 6, 2014

Study Start

July 1, 2014

Primary Completion

April 1, 2015

Study Completion

March 16, 2016

Last Updated

April 13, 2017

Record last verified: 2017-04

Locations